Related Experiment Video

Updated: Jun 10, 2026

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights
07:25

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights

Published on: October 13, 2023

Pathogenesis of Sjögren's syndrome and therapeutic consequences

Xavier Mariette1, Jacques-Eric Gottenberg

  • 1Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Université Paris-Sud 11, Institut Pour la Santé et la Recherche Médicale U1012, Le Kremlin Bicêtre, France. xavier.mariette@bct.aphp.fr

Current Opinion in Rheumatology
|July 31, 2010
PubMed
Abstract

Insights

Recent findings reveal genetic and environmental factors interacting with innate and adaptive immunity in primary Sjögren

Area of Science:

  • Immunology
  • Genetics
  • Rheumatology

Background:

  • Primary Sjögren's syndrome involves complex interactions between genetic and environmental factors.
  • Both innate and adaptive immune system dysregulation contribute to disease pathogenesis.

Purpose of the Study:

  • To review recent discoveries in the pathogenic mechanisms of primary Sjögren's syndrome.
  • To connect disease pathogenesis with potential therapeutic targets for emerging treatments.

Main Methods:

  • Review of recent findings on genetic and environmental factors in Sjögren's syndrome.
  • Analysis of immune system interactions (innate and adaptive) in disease development.
  • Focus on critical pathogenic steps for targeted therapy development.

Main Results:

  • IRF5 and STAT4 gene polymorphisms are linked to type I interferon pathway activation.
  • Innate immune stimulation in mice can induce dryness preceding lymphocytic infiltrates.
  • Environmental factors like estrogen deficiency and Epstein-Barr virus infection trigger autoimmune epithelitis.
  • The IFN-BAFF-B lymphocyte axis is a key target for new drugs.
  • The first positive rituximab trial in Sjögren's syndrome has been reported.

Conclusions:

  • Understanding Sjögren's syndrome pathogenesis is crucial for identifying new therapeutic targets.
  • Continued research efforts are expected to yield novel treatment strategies.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...